Cool to see this from Brian Hie, who was doing interesting computational bio research at Meta's FAIR before they axed it. Interesting that this is work on the more physical/testing/manufacturing level than the computational, but it seems very useful. It's hard to quantify the impact of new foundational tools like this at launch. Most of the time it falls flat, but even the successes are difficult. For example, CRISPR…
Why do you think that?